Hussain , A and Patwekar, U and Mongad , DS and Shouche, YS (2022) Strategizing the human microbiome for small molecules: approaches and perspectives. Drug Discovery Today. 2022 Nov 23;103459. (103459).

Full text not available from this repository. (Request a copy)

Abstract

Studies of the human microbiome are providing a deeper understanding of its significance to human health, and increasing evidence links the microbiota with several diseases. Nevertheless, the exact mechanisms involved in human–microbe interactions are mostly undefined. The genomic potential of the human microbiome to biosynthesize distinct molecules outmatches its known chemical space, and small-molecule discovery in this context remains in its infancy. The profiling of microbiome-derived small molecules and their contextualization through cause–effect mechanistic studies may provide a better understanding of host–microbe interactions, guide new therapeutic interventions, and modulate microbiome-based therapies. This review describes the advances, approaches, and allied challenges in mining new microbial scaffolds from the human microbiome using genomic, microbe cultivation, and chemical analytic platforms. In the future, the complete biological characterization of a single microbe-derived molecule that has a specific therapeutic application could resolve the current limitations of microbiota-modulating therapies.

Item Type:	Article
Subjects:	Insect Molecular Biology
Depositing User:	Mr. Rameshwar Nema
Date Deposited:	03 Jan 2023 07:26
Last Modified:	03 Jan 2023 07:26
URI:	http://nccs.sciencecentral.in/id/eprint/1225

Actions (login required)

View Item